NIZORAL PSORIASIS RELIEF- salicylic acid cream

Nizoral Psoriasis Relief by

Drug Labeling and Warnings

Nizoral Psoriasis Relief by is a Otc medication manufactured, distributed, or labeled by Kramer Laboratories. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

• Active ingredient: Purpose
• Salicylic Acid 3.0%: Psoriasis

Uses

• for the relief of itching, scaling, redness, flaking, and irritation associated with psoriasis
• helps prevent recurrence of psoriasis symptoms

WARNINGS

Warnings
For external use only

Ask a doctor before use if

• condition covers a large area of the body

When using this product

• Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask doctor if

• condition worsens or does not improve after regular use of this product as directed
  

KEEP OUT OF REACH OF CHILDREN

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

• apply to affected areas one to four times daily or as directed by a doctor
  

Other information

• store product at 20-25°C (68-77°F)
• keep carton for full product information.

Inactive ingredients

allantoin, arachidyl alcohol, arachidyl glucoside, beeswax, behenyl alcohol, benzyl alcohol, butyrospermum parkii(shea) butter, cetearyl alcohol, chlorphenesin, cyclopentasiloxane, dimethicone, disodium EDTA, ethylhexyl isononanoate, glyceryl stearate, hydrogenated polydecene, isododecane, isosorbide dicaprylate, laureth-4, laureth-23, panthenol, PEG-100 stearate, PEG-7 trimethylolpropane coconut ether, propylene glycol, sodium hydroxide, tocopheryl acetate, water, xanthan gum

QUESTIONS

Questions? 1-800-824-4894

PRINCIPAL DISPLAY PANEL

NEW

Nizoral®

Psoriasis
Relief Cream
SALICYLIC ACID 3%

For Psoriasis Affected Skin

RELIEVES
Itching, Irritation & Redness

CONTROLS
Flaking & Scaling

HELPS PREVENT
Recurrence of
Psoriasis Symptoms

FAST-ACTING
Starts Working from First Use

Free of Fragrance, Steroids,
Dyes & Parabens

Net wt 4 oz (113 g)

Specially
formulated
with:
√  Shea Butter
√  Vitamin B5
√  Vitamin E

Free of:
Ⅹ  Steroids
Ⅹ  Fragrances
Ⅹ  Dyes
Ⅹ  Parabens

Before use, read all label
information. If you have
a drug reaction, contact
a doctor and report it by
calling:
1.800.824.4894

Distributed by:
Kramer Laboratories, Inc.
Bridgewater, NJ 08807 
USA

© 2023 KRAMER
LABORATORIES, INC.

K0723

INGREDIENTS AND APPEARANCE

NIZORAL PSORIASIS RELIEF 
salicylic acid cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 55505-224
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ)	Salicylic Acid	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
Allantoin (UNII: 344S277G0Z)
Arachidyl Alcohol (UNII: 1QR1QRA9BU)
Arachidyl Glucoside (UNII: 6JVW35JOOJ)
Yellow Wax (UNII: 2ZA36H0S2V)
Benzyl Alcohol (UNII: LKG8494WBH)
Shea Butter (UNII: K49155WL9Y)
Cetostearyl Alcohol (UNII: 2DMT128M1S)
Chlorphenesin (UNII: I670DAL4SZ)
Cyclomethicone 5 (UNII: 0THT5PCI0R)
Dimethicone (UNII: 92RU3N3Y1O)
Disodium Edta-Copper (UNII: 6V475AX06U)
Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM)
Glyceryl Stearate Citrate (UNII: WH8T92A065)
Hydrogenated Polydecene Type I (UNII: U333RI6EB7)
Isododecane (UNII: A8289P68Y2)
Isosorbide Dicaprylate (UNII: 0IK29C4889)
Laureth-4 (UNII: 6HQ855798J)
Laureth-23 (UNII: N72LMW566G)
Panthenol (UNII: WV9CM0O67Z)
Peg-100 Stearate (UNII: YD01N1999R)
Peg-7 Trimethylolpropane Coconut Ether (UNII: MVJ3AD73GG)
Propylene Glycol (UNII: 6DC9Q167V3)
Sodium Hydroxide (UNII: 55X04QC32I)
.Alpha.-Tocopherol Acetate (UNII: 9E8X80D2L0)
Water (UNII: 059QF0KO0R)
Xanthan Gum (UNII: TTV12P4NEE)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 55505-224-33	1 in 1 CARTON	01/01/2024
1		113 g in 1 JAR; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M032	01/01/2024

Labeler - Kramer Laboratories (122720675)